CD163 and esophageal squamous cell carcinoma: Finally, the subgroup analyses were conducted according to different TAMs markers (CD68, CD163 and CD204) and histologic locations (TI+TS, TI, and TS) to assess the effect of TAMs on the prognosis of ESCC, including OS and DFS, which made our pooled analysis more informative and persuasive.